Vasquez Nicki's most recent trade in Sutro Biopharma Inc was a trade of 12,185 Common Stock done at an average price of $5 . Disclosure was reported to the exchange on Jan. 29, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Nicki Vasquez | CHIEF PORT. STRAT & ALNCE OFCR | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 29 Jan 2024 | 12,185 | 12,803 (0%) | 0% | 5 | 60,925 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | CHIEF PORT. STRAT & ALNCE OFCR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 2,500 | 15,303 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Vasquez Nicki | CHIEF PORT. STRAT & ALNCE OFCR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 2,500 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | CHIEF PORT. STRAT & ALNCE OFCR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.99 per share. | 29 Jan 2024 | 1,024 | 14,279 (0%) | 0% | 5.0 | 5,110 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2023 | 3,250 | 26,111 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2023 | 3,250 | 6,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.70 per share. | 12 Jul 2023 | 1,123 | 24,988 (0%) | 0% | 4.7 | 5,278 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 25,000 | 25,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 6,750 | 22,351 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 6,750 | 20,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 5,500 | 27,851 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 5,500 | 11,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.79 per share. | 03 Mar 2023 | 4,990 | 22,861 (0%) | 0% | 5.8 | 28,892 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 2,500 | 16,620 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2023 | 2,500 | 2,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 27 Jan 2023 | 1,019 | 15,601 (0%) | 0% | 7.5 | 7,643 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2022 | 3,250 | 15,243 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2022 | 3,250 | 9,750 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.08 per share. | 12 Jul 2022 | 1,123 | 14,120 (0%) | 0% | 6.1 | 6,828 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 36,000 | 36,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 27,000 | 27,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 5,500 | 14,246 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 5,500 | 16,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.17 per share. | 04 Mar 2022 | 2,253 | 11,993 (0%) | 0% | 8.2 | 18,407 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 2,500 | 9,770 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 2,500 | 5,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.39 per share. | 29 Jan 2022 | 1,024 | 8,746 (0%) | 0% | 10.4 | 10,639 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 5,969 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 5,969 | 13,239 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Sale of securities on an exchange or to another person at price $ 18.62 per share. | 24 Sep 2021 | 3,906 | 7,270 (0%) | 0% | 18.6 | 72,724 | Common Stock |
| Sutro Biopharma Inc | Nicki Vasquez | Chief Port. Strat & Alnce Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.23 per share. | 24 Sep 2021 | 2,063 | 11,176 (0%) | 0% | 19.2 | 39,671 | Common Stock |